Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine.
Cutis
; 109(1): E5-E7, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1707291
ABSTRACT
Herpes zoster (HZ) was suspected as a predictive cutaneous manifestation of COVID-19, with a debated prognostic significance. We report a series of 5 cases of HZ occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine (Comirnaty, Pfizer-BioNTech). These new cases do not prove causality between COVID-19 vaccination and HZ. The pathophysiologic mechanism remains elusive, but local vaccine-induced immunomodulation may be involved. The occurrence of HZ does not justify avoiding the second injection of vaccine due to the benefit of vaccination.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Herpes Zoster Vaccine
/
COVID-19
/
Herpes Zoster
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Cutis
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS